Knowledge management: “Shaken or stirred – methods of pharmaceutical development”

During the ClinTriCare company meeting on 21 and 22 September 2017, we invited an expert who shed light on what he described as the “Black box IMP”. The speaker is a pharmacist specializing in clinical pharmacy and for 20 years has been working for one of the largest research-based pharmaceutical companies in Germany. He specializes in pharmaceutical development of medicines and the supply of investigational medicinal products (IMP) for clinical trials.

This continuing education event featured a lot of interesting information about the challenges of the blinding of trial medication and was able to impart important background knowledge to the ClinTriCare staff about the IMP-related processes during the conduct of clinical trials.